GlobeNewsWire
29 Jul 2026, 15:40 UTC · 7h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
5 claims · each scored for market impact
GeneDx cut its 2026 revenue guidance from $540–$555 million down to $475–$490 million. — Significant downward revisions to revenue guidance typically trigger immediate negative price action and lower valuation multiples.
-0.80GeneDx recognized a $31.3 million goodwill impairment charge on the Fabric Genomics acquisition, which was purchased for $36.5 million only a year prior. — Wiping out nearly the entire value of a recent acquisition indicates a failed strategic move and severe overpayment, damaging management credibility.
-0.70A federal securities class action lawsuit has been filed alleging GeneDx misled investors regarding reimbursement rate durability and the value of Fabric Genomics. — Legal proceedings for securities fraud introduce long-term liability risks and potential settlement costs.
-0.50Continue reading
6 related stories
Top 3 movers · tap to explore
GeneDx reported a miss in Q1 financial results for both its exome and genome product lines. — Broad misses across primary product lines suggest systemic operational issues rather than a niche failure.
-0.40The company's average reimbursement rate came in at $3,300, which was $200 below expectations. — Lower-than-expected reimbursement rates directly squeeze gross margins and reduce the lifetime value of customers.
-0.30Which stocks this story touches
The company is facing a securities class action lawsuit following a 49% share price drop, missed financial results, and lowered guidance.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Newsfile Corp
3h ago
